Analysis Else Nutrition Holdings Inc. (BABYF)
6/3/2024
Analysis of Else Nutrition Holdings Inc. (BABYF)
Else Nutrition Holdings Inc. is a company that specializes in plant-based baby and toddler nutrition products. Looking at the recent data for the stock symbol BABYF, we can see that the price has been fluctuating between 0.15000 and 0.17000 over the past few days.Key indicators such as the Relative Strength Index (RSI), Moving Average Convergence Divergence (MACD), and Moving Averages (MA) suggest that the stock is currently in a consolidation phase. The RSI values are around 35-40, indicating neither overbought nor oversold conditions. The MACD histogram is close to zero, suggesting a balance between buying and selling pressure.
The Moving Averages (SMA, EMA, WMA) are also converging, indicating a lack of clear trend direction. This could mean that the stock is trading sideways or preparing for a potential breakout in the near future.
Investors should closely monitor the price levels of 0.15000 and 0.17000 as potential support and resistance levels. A breakout above 0.17000 could signal a bullish trend, while a drop below 0.15000 could indicate a bearish trend.
Overall, Else Nutrition Holdings Inc. shows signs of consolidation and indecision in the short term. Traders should wait for a clear trend confirmation before making any significant trading decisions.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the previous year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for both the upcoming quarters and the next two fiscal years.
Revenue estimate
The analysts' estimates for the future quarterly and annual sales of the company indicate a steady growth trend.For the current quarter ending on June 30, 2024, the average estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
Looking ahead to the next quarter ending on September 30, 2024, the average estimate increases to $85,501,800,000, with a sales growth of 3% compared to the previous year. Again, 25 analysts have provided estimates for this period.
For the current fiscal year ending on September 30, 2024, the average estimate for total sales is $357,772,000,000, showing a 1% growth compared to the previous fiscal year. The number of analysts providing estimates for the full year has increased to 38.
In the following fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, indicating a more significant growth of 6% compared to the current fiscal year. The number of analysts remains at 38.
Overall, the estimates suggest a positive outlook for the company's sales performance, with a consistent growth trajectory in both the short and long term.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest that the company is expected to experience a moderate growth rate in the near term, with a slightly higher growth rate projected for the next year. However, compared to the high growth rate seen in the past 5 years, the future growth rate is expected to be more moderate but still positive.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median and average price above the current price. However, there is a wide range of estimates, from $164 to $275, indicating some uncertainty in the predictions.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results on February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at a specific time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price summary shows volatility with a beta of 1.264 and a fluctuation between the fifty-two-week low and high.
Valuation metrics reveal a high PEG ratio and price-to-book ratio, with the company being relatively expensive based on its forward and trailing P/E ratios. The enterprise value, market capitalization, and other ratios indicate the company's valuation in the market.
Lastly, dividends and splits information show the company's dividend history, payout ratio, and upcoming dividend dates. The company has a consistent dividend yield and has undergone a stock split in the past.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company has experienced a general increase in revenue over the past four years.
- There was a significant jump in revenue from FY 2020 to FY 2021, followed by a slight decrease in FY 2022 and another increase in FY 2023.
- Overall, the company's revenue has been on an upward trajectory, indicating growth and potentially successful business operations.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching the highest value of $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching the highest value of $302,083,000,000 in 2022.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
6. The company seems to be investing more in non-current assets over the years, which might indicate long-term growth strategies.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
MACD of BABYF
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
